NASDAQ:VRNM - Verenium Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.99 0.00 (0.00 %)
(As of 06/25/2018 03:56 AM ET)
Previous Close$3.99
Today's RangeN/A
52-Week Range$2.00 - $4.00
VolumeN/A
Average Volume240,414 shs
Market Capitalization$51.01 million
P/E RatioN/A
Dividend YieldN/A
Beta0.83
Verenium logoVerenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. As of December 31, 2012, it marketed commercial enzyme products, either independently or in collaboration with its partners. In addition, it has developed a pipeline of enzyme product candidates. Its products are organized into four product lines: animal health and nutrition, grain processing, oilfield services and other industrial processes. As of December 31, 2012, it markets nine commercial enzyme products. In October 2013, BASF SE acquired 71% stake in the Company.

Receive VRNM News and Ratings via Email

Sign-up to receive the latest news and ratings for VRNM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:VRNM
CUSIPN/A
WebN/A
Phone+1-858-4318500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

The Truth About Cryptocurrencies

Verenium (NASDAQ:VRNM) Frequently Asked Questions

What is Verenium's stock symbol?

Verenium trades on the NASDAQ under the ticker symbol "VRNM."

Who are Verenium's key executives?

Verenium's management team includes the folowing people:
  • James H. Cavanaugh Ph.D., Independent Chairman of the Board (Age 77)
  • James E. Levine, President, Chief Executive Officer, Director (Age 43)
  • Jeffrey G. Black, Chief Financial Officer, Senior Vice President (Age 48)
  • Janet S. Roemer, Chief Operating Officer, Executive Vice President - Specialty Enzymes Business Unit (Age 57)
  • Alexander A. Fitzpatrick, Senior Vice President, General Counsel, Secretary (Age 47)
  • John F. Dee, Independent Director (Age 56)
  • Peter R Johnson, Independent Director (Age 61)
  • Fernand J. Kaufmann, Independent Director (Age 70)
  • Holger A. Liepmann, Independent Director (Age 63)
  • Joshua Ruch, Independent Director

Has Verenium been receiving favorable news coverage?

News headlines about VRNM stock have trended somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Verenium earned a coverage optimism score of 0.19 on Accern's scale. They also assigned news articles about the biotechnology company an impact score of 46.27 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Verenium?

Shares of VRNM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Verenium's stock price today?

One share of VRNM stock can currently be purchased for approximately $3.99.

How big of a company is Verenium?

Verenium has a market capitalization of $51.01 million.

How can I contact Verenium?

Verenium's mailing address is 3550 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-4318500.


MarketBeat Community Rating for Verenium (VRNM)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  149
MarketBeat's community ratings are surveys of what our community members think about Verenium and other stocks. Vote "Outperform" if you believe VRNM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRNM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.